Skip to content

Monday, July 27, 2026·

Log In Subscribe

Sign up Sign in

Latest
Calendar
City Hall
Business
Culture
Sports

Log In

Latest
City Hall
Housing
Politics
Education
Business
Culture
Community
Food & Drink
Public Safety
Sports
Opinion

About Us
Editorial Standards
Contact Us
Membership
Advertise With Us
Shop

research

1 article

UCR Startup Receives $2.25 Million to Test New Cancer Drug

Education

UCR Startup Receives $2.25 Million to Test New Cancer Drug

Riverside company's treatment targets aggressive tumors including pancreatic cancer.

Gazette Staff Sep 17, 2025

Prev Page 1 of 1 Next

Always know what's going on in Riverside

Let us email you Riverside's news and events every morning. For free!

Great! Check your inbox and click the link.

Sorry, something went wrong. Please try again.

About
Standards
Contact

Membership
Advertise
Shop

© 2026 The Raincross Gazette. All Rights Reserved. Terms of Use Privacy Policy

Already a subscriber? Sign in

Always know what's happening in Riverside

Join the 16,097 other Riversiders who start their day with The Gazette

Great! Check your inbox and click the link.

Sorry, something went wrong. Please try again.

Always free, no spam ever, and we'll never share your email.

Already a subscriber? Sign in

Always know what's happening in Riverside

Join the 16,097 other Riversiders who start their day with The Gazette

Great! Check your inbox and click the link.

Sorry, something went wrong. Please try again.

Always free, no spam ever, and we'll never share your email.

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to The Raincross Gazette.

Your link has expired.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.